# In the Real World Study, the Efficacy and Adverse Reactions of Ticagrelor on Ischemic Cerebrovascular Disease

> **NCT05716646** · — · NOT_YET_RECRUITING · sponsor: **Qianfoshan Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Cerebral Infarction
- Stroke
- Nervous System Diseases
- Ischemic Cerebrovascular Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05716646
- **Lead sponsor:** Qianfoshan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-04
- **Primary completion:** 2028-12
- **Final completion:** 2028-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05716646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05716646, "In the Real World Study, the Efficacy and Adverse Reactions of Ticagrelor on Ischemic Cerebrovascular Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05716646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*